BioCentury
ARTICLE | Company News

Covis, Concordia Healthcare deal

June 1, 2015 7:00 AM UTC

Concordia completed its acquisition of Covis’ commercial assets, specifically its 18 branded and generic products, for $1.2 billion in cash (see BioCentury, March 16). ...